# SHORTER (NCT04422132)

> Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04422132
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Weill Medical College of Cornell University
- Conditions: Prostate Cancer
- Interventions: 5 days Radiation Therapy (32.5 Gy in 5 fractions); 20 days Radiation therapy (55 Gy in 20 fractions)
- Enrollment: 137
- Primary outcome: Change in the Number of Patient-reported GI Symptoms Using the Expanded Prostate Cancer Index Composite (EPIC)
- Primary outcome: Change in the Number of Patient-reported GI Symptoms Using the Expanded Prostate Cancer Index Composite (EPIC)
- Primary outcome: Change in the Number of Patient-reported GU Symptoms Using the Expanded Prostate Cancer Index Composite (EPIC)
- Primary outcome: Change in the Number of Patient-reported GU Symptoms Using the Expanded Prostate Cancer Index Composite (EPIC)

## Indexed commentary on SHORTER so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 3 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=shorter-nct04422132